Butterfly Network Inc
BFLY1.446USD
+0.046+3.26%
Market hours （ET）Quotes delayed by 15 min
362.92MMarket Cap
LossP/E TTM
More Details of Butterfly Network Inc Company
Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.
Company Info
Ticker SymbolBFLY
Company nameButterfly Network Inc
IPO dateMay 26, 2020
CEODr. Joseph M. (Joe) Devivo
Number of employees190
Security typeOrdinary Share
Fiscal year-endMay 26
Address1600 District Avenue
CityBURLINGTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code01803
Phone17815574800
Websitehttps://www.butterflynetwork.com/
Ticker SymbolBFLY
IPO dateMay 26, 2020
CEODr. Joseph M. (Joe) Devivo
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Chief Financial & Operations Officer and Corporate Secretary
Chief Financial & Operations Officer and Corporate Secretary
893.66K
-6.82%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Elazer Edelman, M.D., Ph.D.
Dr. Elazer Edelman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Erica G. Schwartz, M.D., J.D.
Dr. Erica G. Schwartz, M.D., J.D.
Independent Director
Independent Director
--
--
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Chief Financial & Operations Officer and Corporate Secretary
Chief Financial & Operations Officer and Corporate Secretary
893.66K
-6.82%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
By BusinessUSD
Name
Revenue
Proportion
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
By RegionUSD
Name
Revenue
Proportion
United States
17.04M
80.28%
International
4.19M
19.72%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Shareholding Stats
Updated: Thu, May 22
Updated: Thu, May 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Shareholders
Shareholders
Proportion
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Shareholder Types
Shareholders
Proportion
Investment Advisor
24.01%
Hedge Fund
10.38%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
6.98%
Holding Company
4.85%
Corporation
2.06%
Research Firm
2.03%
Foundation
0.46%
Pension Fund
0.31%
Other
40.26%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
452
132.08M
59.80%
+19.64M
2025Q1
463
134.83M
61.70%
+30.88M
2024Q4
439
95.60M
44.26%
+1.75M
2024Q3
436
81.98M
42.82%
-15.90M
2024Q2
437
84.70M
45.43%
-25.58M
2024Q1
443
102.66M
55.89%
-10.36M
2023Q4
445
101.26M
55.91%
-15.86M
2023Q3
456
105.48M
58.39%
-19.66M
2023Q2
472
110.05M
61.35%
-5.29M
2023Q1
486
98.46M
55.67%
-23.16M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fosun International Ltd
10.72M
4.85%
--
--
Mar 31, 2025
Glenview Capital Management, LLC
9.96M
4.51%
--
--
Jun 13, 2025
Rothberg (Jonathan M)
9.65M
4.37%
+80.43K
+0.84%
Jun 13, 2025
The Vanguard Group, Inc.
8.57M
3.88%
+1.13M
+15.21%
Mar 31, 2025
Capital Research Global Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
Capital World Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
ARK Investment Management LLC
7.02M
3.18%
+1.01M
+16.84%
Mar 31, 2025
First Light Asset Management, LLC
5.51M
2.49%
+1.51M
+37.83%
Mar 31, 2025
Hood River Capital Management LLC
4.95M
2.24%
+4.95M
--
Mar 31, 2025
Longview Investors LLC
4.55M
2.06%
--
--
Jun 13, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
ARK Genomic Revolution ETF
1.23%
SPDR S&P Health Care Equipment ETF
0.81%
Global X HealthTech ETF
0.37%
SPDR S&P Kensho New Economies Composite ETF
0.16%
iShares Micro-Cap ETF
0.09%
iShares U.S. Medical Devices ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
Global X Russell 2000 ETF
0.02%
View more
ARK Genomic Revolution ETF
Proportion1.23%
SPDR S&P Health Care Equipment ETF
Proportion0.81%
Global X HealthTech ETF
Proportion0.37%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.16%
iShares Micro-Cap ETF
Proportion0.09%
iShares U.S. Medical Devices ETF
Proportion0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 Growth ETF
Proportion0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.03%
Global X Russell 2000 ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
